Sihuan Pharmaceutical aims to raise $740 million in Hong Kong IPO

If successful, this will be the second Chinese medical company in the past month to transfer listings from another stock exchange to Hong Kong.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES